:::

詳目顯示

回上一頁
題名:2012年臺北市5歲以下兒童肺炎鏈球菌結合疫苗接種率及其影響因素研究
書刊名:臺灣公共衛生雜誌
作者:林國甯陳政友 引用關係蔡炯青 引用關係朱玉如
作者(外文):Lin, Kuo-ningChen, Cheng-yuTsai, Chiung-chingChu, Yu-roo
出版日期:2013
卷期:32:5
頁次:頁463-475
主題關鍵詞:疫苗接種肺炎鏈球菌疫苗健康信念VaccinationPneumococcal conjugate vaccineHealth belief
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:4
  • 點閱點閱:45
目標:本研究調查2012年台北市5歲以下兒童接種肺炎鏈球菌結合疫苗(PCV)情形及探討影響接種之因素。方法:以全國預防接種資訊管理資料庫系統(National Immunization Information System,NIIS)系統中台北市家中育有5歲以下兒童之家戶為母群,依台北市12個行政區採分層隨機抽樣,以各區家中育有5歲以下兒童之家戶數比例配置各分層樣本數,於2012年12月抽取樣本進行電話訪問調查。有效樣本707份,以卡方、點二系列相關及邏輯斯複迴歸分析兒童接種PCV之相關因素。結果:台北市家中5歲以下兒童已接種PCV者逾八成,以邏輯斯複迴歸分析顯示父親年齡、主要照顧者自覺對兒童感染肺炎鏈球菌之罹患性、自覺疫苗有效性等健康信念為影響疫苗接種之統計顯著因素。結論:為提升主要照顧者自覺兒童感染肺炎鏈球菌之罹患性及疫苗有效性等認知,建議衛生機關可於衛教宣導海報及單張,完整呈現疾病侵襲風險、疫苗成份及保護效果等資訊,供主要照顧者決策時參考。且建議未來可對台北市進行PCV疫苗接種率與群體免疫的效益研究。
Objectives: The aim of this study was to investigate the factors influencing the rate of Pneumococcal Conjugate Vaccine (PCV) vaccination of children under 5 years of age in Taipei City during 2012. Methods: Based on data from the National Immunization Information System (NIIS), we selected families with children under 5 years of age in Taipei City as the study population. We adopted the stratified random sampling method to sample 12 administrative districts in Taipei City and allocated samples proportionally according to the number of families in each district. In December 2012, a computer assisted telephone interview was conducted. We used chi-square tests, point-biserial correlations, and a multiple logistic regression model to analyze the 707 valid samples. Results: The PCV vaccination rate of children under 5 years of age in Taipei City exceeded 80%. After multiple logistic regression analysis, we found that the statistically significant factors influencing PCV vaccination were: father's age and primary caregiver's acknowledgement of health beliefs such as perceived susceptibility to invasive pneumococcal disease (IPD) and PCV's effectiveness. Conclusions: In order to raise primary caregivers' acknowledgement of perceived susceptibility to IPD and the effectiveness of PCV, we suggest that the health authorities provide more comprehensive information for the public. Campaign materials might include educational posters and brochures in which the severity of IPD and the ingredients and protective effects of PCV shots are explained. We also suggest further research on vaccination and herd immunity based on the PCV vaccination rate in Taipei city.
期刊論文
1.Robinson, K. A.、Baughman, W. S.、Rothrock, G.(2001)。Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era。JAMA,285,1729-1735。  new window
2.陳英彥、陳雅惠、程筱雯(2011)。侵襲性肺炎鏈球菌感染症在2008-2010年台灣各地區流行概況。疫情報導,27,297-304。  延伸查詢new window
3.Kieninger, D. M.、Kueper, K.、Steul, K.(2010)。Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany。Vaccine,28,4192-4203。  new window
4.Li, R. C.、Li, F. X.、Li, Y. P.(2008)。Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar): primary dosing series in healthy Chinese infants。Vaccine,26,2260-2269。  new window
5.Esposito, S.、Tansey, S.、Thompson, A.(2010)。Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers。Clin Vaccine Immunol,17,1017-1026。  new window
6.Paradiso, P. R.(2011)。Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children。Clin Infect Dis,52,1241-1247。  new window
7.廖彩涵、楊銘欽(20120800)。影響家長讓小孩接種肺炎鏈球菌疫苗之相關因素:網路調查之應用。臺灣公共衛生雜誌,31(4),361-370。new window  延伸查詢new window
8.Poehling, K. A.、Talbot, T. R.、Griffin, M. R.(2006)。Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine。JAMA,295,1668-1674。  new window
9.Talbot, T. R.、Poehling, K. A.、Hartert ,T. V.(2004)。Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine。Pediatr Infect Dis J,23,726-731。  new window
10.Haber, M.、Barskey, A.、Baughman, W.(2007)。Herd immunity and pneumococcal conjugate vaccine: a quantitative model。Vaccine,25,5390-5398。  new window
11.黎伊帆、江東亮(20110600)。臺灣兒童疫苗接種的社會差異:以三合一疫苗及流感疫苗為例。臺灣公共衛生雜誌,30(3),257-264。new window  延伸查詢new window
12.許淑雲、廖宏恩、洪百薰、林柏煌、高昆裕、王俊毅(20100800)。國小低年級學童家長對其子女接種流感疫苗意向之轉變情形及其相關因素分析--以雲林縣學童家長為例。臺灣公共衛生雜誌,29(4),326-336。new window  延伸查詢new window
13.Janz, Nancy K.、Becker, Marshall H.(1984)。The Health Belief Model: A decade later。Health Education Quarterly,11(1),1-47。  new window
14.Chen, M. F.、Wang, R. H.、Schneider, J. K.(2011)。Using the health belief model to understand caregiver factors influencing childhood influenza vaccinations。J Community Health Nurs,28,29-40。  new window
15.Kyaw, M. H.、Lynfield, R.、Schaffner, W.(2006)。Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant streptococcus pneumoniae。N Engl J Med,354,1455-1463。  new window
16.Nowalk, M. P.、Lin, C. J.、Zimmerman, R. K.(2007)。Changes in parents’ perceptions of infant influenza vaccination over two years。J Natl Med Assoc,99,636-641。  new window
圖書
1.王志堅(2002)。肺炎鏈球菌。感染與疫苗。臺北:李慶雲醫學文教基金會。  延伸查詢new window
2.Link, B. G.、Phelan, J. C.(2000)。Evaluating the fundamental cause explanation for social disparities in health。Handbook of Medical Sociology。New Jersey:Prentice Hall。  new window
其他
1.衛生福利部疾病管制署(2011)。致醫界通函第105號,http://www.cdc.gov.tw/professional/info.aspx?treeid=CF7F90DCBCD5718D&nowtreeid=0441F6EEB625A9C1&tid=F25728E788ACB48E, 2011/06/09。  new window
2.台灣兒科醫學會(2013)。臨床建議與指引,http://www.pediatr.org.tw/member/bedside.asp, 2013/05/27。  延伸查詢new window
3.衛生福利部疾病管制署(2013)。傳染病防治工作手冊,http://www.cdc.gov.tw/professional/info.aspx?treeid=4c19a0252bbef869&nowtreeid=4dc827595f55c334&tid=BB4AA2938062AD61, 2013/05/27。  延伸查詢new window
4.European Medicines Agency(2009)。Licenced medicines,http://www.ema.europa.eu, 2009/09/12。  new window
5.衛生福利部疾病管制署(2011)。ACIP會議紀錄,http://www.cdc.gov.tw/list.aspx?treeid=D78DE698C2E70A89&nowtreeid=CFB77829C7ABD761, 2011/03/24。  new window
6.衛生福利部疾病管制署。預防接種重點訊息,http://www.cdc.gov.tw/professional/index.aspx, 2011/07/19。  延伸查詢new window
7.臺北市政府衛生局。北市幼童新福利 13價肺炎鏈球菌疫苗開打,http://www.health.gov.tw/Default.aspx?tabid=699&mid=2034&itemid=29276, 2011/12/29。  延伸查詢new window
8.衛生福利部疾病管制署(2014)。預防接種專區,http://www.cdc.gov.tw/vaccinationtheme.aspx?treeid=d78de698c2e70a89&nowtreeid=aae079470c4424c3, 2013/02/19。  延伸查詢new window
9.WHO ETAGE(2012)。Draft global vaccine action plan,http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_22-en.pdf, 2012/05/11。  new window
10.臺北市政府衛生局。肺炎鏈球菌疫苗,http://www.health.gov.tw/Default.aspx?tabid=699, 2012/12/25。  延伸查詢new window
11.臺北市政府衛生局。台北市嬰幼兒疫苗「三好」福利政策,2012,http://www.health.gov.tw/Default.aspx?tabid=741, 2012/12/24。  延伸查詢new window
12.王昶閔。衛署建議:加打新疫苗抗肺炎鏈球菌19A型,http://www.libertytimes.com.tw/2010/new/dec/18/today-health3.htm, 2012/12/18。  延伸查詢new window
13.內政部統計處(2012)。內政統計年報,http://sowf.moi.gov.tw/stat/year/y02-01.xls, 2012/12/31。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top